Bluejay Therapeutics
ClosedSan Mateo, United States · $182.0M raised
- Headquarters
- San Mateo
- Website
- bluejaytx.com
- Total Funding
- $182.0M
- Last Round
- $182.0M Series CMay 2024
- Rounds
- 1
About
Bluejay Therapeutics is a clinical-stage biopharmaceutical developer focused on potentially life-changing treatments for viral hepatitis and liver diseases. The company is investigating BJT-778 for chronic hepatitis B and chronic hepatitis D. It is also advancing programs targeting chronic hepatitis B, including the TLR9 agonist cavrotolimod and liver-targeted hepatitis B virus transcript inhibitor BJT-628, toward a combination regimen intended to achieve a functional cure.
Summary
Bluejay Therapeutics is a Biotech company based in San Mateo, United States. It has raised $182.0M in total across 1 round, most recently a $182.0M Series C round in May 2024.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
May 2024
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/bluejay-therapeutics"><img src="https://indexed.vc/api/badge/company/bluejay-therapeutics" alt="Bluejay Therapeutics on Indexed.vc" width="260" height="76" /></a>